Evidence map›Paper›PMID 18832066›Full record

ArticleGenes & development2008

Polo-like kinase Cdc5 drives exit from pachytene during budding yeast meiosis.

Anuradha Sourirajan, Michael Lichten

Open access · diamondAbstract readComment
In one paragraph

Article in Genes & development, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 135 papers.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

135 citing papers in PubMed, 185 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Unravelling the Transcriptional Response ofInternational journal of molecular sciences · 2024
    Article
  19. Article
  20. Article

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Anuradha SourirajanLaboratory of Biochemistry and Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA.
Michael Lichten
National Cancer Institute · US

Funding

Mechanism of Meiotic RecombinationZIABC005268 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LICHTEN, MICHAEL J · 2009 to 2023
$17.3M
MECHANISMS OF MEIOTIC RECOMBINATIONZ01BC005268 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LICHTEN, MICHAEL J · 1996 to 2008
$2.5M
Intramural NIH HHS
6 · The paper itself

Abstract

In budding yeast, exit from the pachytene stage of meiosis requires the mid-meiosis transcription factor Ndt80, which promotes expression of approximately 200 genes. Ndt80 is required for meiotic function of polo-like kinase (PLK, Cdc5) and cyclin-dependent kinase (CDK), two cell cycle kinases previously implicated in pachytene exit. We show that ongoing CDK activity is dispensable for two events that accompany exit from pachytene: crossover formation and synaptonemal complex breakdown. In contrast, CDC5 expression in ndt80Delta mutants efficiently promotes both events. Thus, Cdc5 is the only member of the Ndt80 transcriptome required for this critical step in meiotic progression.

Indexed as

Cell Cycle ProteinsChromosomes, FungalDNA-Binding ProteinsGene Expression ProfilingGenes, FungalMeiosisModels, BiologicalMutationPachytene StageProtein KinasesProtein Serine-Threonine KinasesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSynaptonemal ComplexTranscription FactorsCDC5 protein, S cerevisiaeCell Cycle ProteinsDNA-Binding ProteinsNDT80 protein, S cerevisiaeProtein KinasesProtein Serine-Threonine KinasesSaccharomyces cerevisiae ProteinsTranscription Factors

Identifiers

PMID18832066
PMCPMC2559907
OpenAlexW2065271821

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.